Partners

TB Alliance works with a diverse network of global partners, including the world’s leading pharmaceutical developers, academic institutions, and research institutes. The following organizations are TB Alliance research and development partners.

AbbVie
AIDS Clinical Trial Group (ACTG)
Astellas
Bill & Melinda Gates Foundation
Bill & Melinda Gates Medical Research Institute
Center of Excellence in Translational Research (CETR)
Chugai
Daiichi Sankyo RD Novare
ERA4TB
Erasmus University Rotterdam
EU-Pearl Consortium
Evotec
Foundation for Neglected Disease Research
Fujifilm
GlaxoSmithKline
Global Health Drug Discovery Institute
Harvard University
Hongqi Pharmaceutical
IMPAACT
Institute of Materia Medica
International Tuberculosis Research Center (ITRC)
Janssen
Johns Hopkins University
KNCV Tuberculosefonds
Korea International Cooperation Agency (KOICA)
Lgenia
Lupin
Macleods
Médecins Sans Frontières
Médecins Sans Frontières (MSF) Amsterdam Office
Medical Research Council at University College London
National Center for Advancing Translational Sciences (NCATS)
National Institutes of Health
Otsuka Pharmaceutical
PAN-TB Consortium
PanACEA
Qurient Therapeutics
Radboud University
Schrodinger
Seattle Children's Hospital
Stellenbosch University
Takeda Pharmaceuticals
TB Drug Accelerator Program
Texas A&M University
The Aurum Institute
TropIQ
UNITE4TB Consortium
University College London
University of Auckland
University of Illinois at Chicago
University of North Carolina
University of St. Andrews
Viatris
Weill Cornel Medical
X-Chem
Yonsei University

Search form

Partners